Novartis considers its options for Alcon division

26 January 2017 - Deborah Wilkes

Archived

Novartis is considering "all options" for its Alcon eyecare division, ranging from retaining the business to exiting the business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: